Literature DB >> 6982967

Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.

Y Yonekura, R S Benua, A B Brill, P Som, S D Yeh, N E Kemeny, J S Fowler, R R MacGregor, R Stamm, D R Christman, A P Wolf.   

Abstract

Three patients with liver metastases from colon carcinoma were studied with 2-deoxy-2-[F-18]fluoro-d-glucose (F-18-FDG) using positron emission tomography. The radioactivity in the metastatic tumor increased continuously following the injection of F-18-FDG, whereas it decreased in normal liver tissue. This resulted in the tumor to normal-liver ratio of 3.3-4.7 at 50 min after injection. The liver tumor was visualized as an increased accumulation of radioactivity in all patients, with the central area of the tumor showing less activity. These preliminary results suggest that F-18-FDG may be useful as a positive imaging agent for the detection and characterization of liver tumors.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6982967

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  17 in total

1.  Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.

Authors:  T Miyauchi; R L Wahl
Journal:  Eur J Nucl Med       Date:  1996-05

Review 2.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

3.  Imaging for anaesthetists: a review of the methods and anaesthetic implications of diagnostic imaging techniques.

Authors:  G Weston; L Strunin; G M Amundson
Journal:  Can Anaesth Soc J       Date:  1985-09

4.  On the potential for RF heating in MRI to affect metabolic rates and 18 FDG signal in PET/MR: simulations of long-duration, maximum normal mode heating.

Authors:  Giuseppe Carluccio; Yu-Shin Ding; Jean Logan; Christopher M Collins
Journal:  Med Phys       Date:  2017-01-30       Impact factor: 4.071

5.  Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose.

Authors:  Y Abe; T Matsuzawa; T Fujiwara; H Fukuda; M Itoh; K Yamada; K Yamaguchi; T Sato; T Ido
Journal:  Eur J Nucl Med       Date:  1986

6.  18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.

Authors:  H Joensuu; A Ahonen; P J Klemi
Journal:  Eur J Nucl Med       Date:  1988

7.  Fluorodeoxyglucose cell incorporation as an index of cell proliferation: evaluation of accuracy in cell culture.

Authors:  D O Slosman; N Pittet; A Donath; B S Polla
Journal:  Eur J Nucl Med       Date:  1993-11

8.  Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.

Authors:  J P Crowe; L P Adler; R R Shenk; J Sunshine
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

9.  Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.

Authors:  Erito Mochiki; Hiroyuki Kuwano; Hiroyuki Katoh; Takayuki Asao; Noboru Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

10.  Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.

Authors:  H Friess; J Langhans; M Ebert; H G Beger; J Stollfuss; S N Reske; M W Büchler
Journal:  Gut       Date:  1995-05       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.